Evidence map›Paper›PMID 37894196›Full record

ArticleMicroorganisms2023

Epidemiology and Resistance Phenotypes of Carbapenem-Resistant

Glykeria Sorovou, Georgios Schinas, Aggeliki Pasxali, Angeliki Tzoukmani, Kyriaki Tryfinopoulou, Charalambos Gogos, George Dimopoulos, Karolina Akinosoglou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. In vitro antimicrobial activity and clinical use of trimethoprim-sulfamethoxazole for infections due to KPC-producing Gram-negative pathogens: a review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Glykeria SorovouMicrobiology Laboratory, General Hospital of Corfu, 49100 Corfu, Greece.
Georgios SchinasSchool of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-7963-1865
Aggeliki PasxaliMicrobiology Laboratory, General Hospital of Corfu, 49100 Corfu, Greece.
Angeliki TzoukmaniCentral Public Health Laboratory, National Public Health Organization, 34 Alex. Fleming Str., 16672 Vari, Greece.
Kyriaki TryfinopoulouCentral Public Health Laboratory, National Public Health Organization, 34 Alex. Fleming Str., 16672 Vari, Greece.ORCID 0009-0009-7066-7453
Charalambos GogosSchool of Medicine, University of Patras, 26504 Patras, Greece.
George Dimopoulos3rd Department of Critical Care, Evgenidio Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Karolina AkinosoglouSchool of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-4289-9494

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is a significant global health challenge, with

Indexed as

antibiotic resistance patternsantimicrobial resistancecarbapenem-resistant EnterobacteriaceaeCOVID-19epidemiological monitoringKlebsiella pneumoniaeKPCmolecular monitoringNDMresistance genes

Identifiers

PMID37894196
PMCPMC10608955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.